At a glance

ClinicalIndex Comparison Record

N/ACompleted· 80 enrolled

Drug / intervention

Community-based PA program +1 moreother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04711057

NCT04711057N/ACompleted

Compare CT.gov

CENTR(AR): Lungs Moving

Aveiro University·interventional·Posted Jan 15, 2021·Updated Jan 19, 2024

In Brief

A clinical study evaluating Community-based PA program and Pulmonary Rehabilitation for Chronic Respiratory Disease and 4 related conditions. Completed, enrolled 80 participants across 1 site.

Detailed Summary

Chronic Respiratory Diseases (CRDs) are associated with substantial morbidity and mortality, ranking as the third leading cause of death worldwide. Pulmonary rehabilitation (PR) is a fundamental evidence-based intervention for the management of a variety of CRDs, such as Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Diseases (ILDs). However, the benefits of PR tend to decline over time and there is currently no strong evidence that patients translate those benefits into a more active lifestyle. There is an urgent need for evidence-based interventions to promote physical activity (PA) participation, whilst maintaining PR positive effects in the long-term. Community-based PA interventions adjusted to the local context, as well as patients' needs and preferences, might be a key strategy to meet this target. CENTR(AR) will be a sustainable response to support healthy lifestyles and enhance long-term PR benefits, by providing access to PR within Primary Healthcare Centres (PHC), followed by the inclusion in a community-based PA program, which embraces urban facilities and available resources.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsChronic Respiratory Disease, Lung Diseases, Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease

CountriesPortugal

CollaboratorsPrograma Operacional Inclusão Social e Emprego (POISE), Programa Operacional Competitividade e Internacionalização (POCI) - Compete2020, Portuguese National Funding Agency for Science, Research and Technology (FCT), Aveiro Institute of Biomedicine (iBiMED), School of Health Sciences, University of Aveiro (ESSUA), City Council/Municipality: a) Aveiro; b) Estarreja; c) Oliveira do Bairro; d) Montemor-o-Velho, Administração Regional de Saúde do Centro, Centro Hospitalar do Baixo Vouga (CHBV), E.P.E.

Timeline

N/ACompletedFinished

202120222023202420252026

First PostedJan 2021

Enrollment StartApr 2021

Primary CompletionJun 2023

Study CompletionDec 2023

TodayJul 2026

First PostedJan 15, 2021

Enrollment StartApr 1, 2021

Primary CompletionJun 1, 2023

Study CompletionDec 31, 2023

TodayJul 2, 2026

Enrollment to primary: 2.2 yearsPosted 5.5 years ago

Interventions

Community-based PA programother

After completing the PR program, the experimental group (EG) will enroll in a 6-month personalized community-based PA program, which should be attended twice-weekly, minimum. During the first month the physiotherapist will guide patients through all available physical activities; afterwards, patients will be asked to choose one or two activities, according to their preference, which they'll attend for five more months. Physiotherapists' support will gradually decrease over time.

Pulmonary Rehabilitationother

Exercise training, twice a week, and education and psychosocial support once every other week during 12 weeks.